Log in
Enquire now
‌

US Patent 11417241 Artificial canine model

Patent 11417241 was granted and assigned to Syndaver on August, 2022 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
Syndaver
Syndaver
0
Current Assignee
Syndaver
Syndaver
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
114172410
Patent Inventor Names
Christopher Sakezles0
David Danielson0
Date of Patent
August 16, 2022
0
Patent Application Number
167010760
Date Filed
December 2, 2019
0
Patent Citations
‌
US Patent 10553131 Central line simulation and training device
‌
US Patent 10424226 Chest tube simulation method and training device
‌
US Patent 10354559 Cricothyroidotomy simulation device
Patent Primary Examiner
‌
Kurt Fernstrom
0
CPC Code
‌
G09B 23/28
0
‌
G09B 23/30
0
‌
G09B 23/34
0

Disclosed herein are anatomic models that comprise components that simulate canine components. The models may be used for development, experimentation, or training in the field of orthopedic surgical devices, and/or implant devices. The models may also be used for training of students in the veterinarian field for procedures performed in practice.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11417241 Artificial canine model

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.